Author:
Humm Bernhard G.,Walsh Paul
Publisher
Springer Berlin Heidelberg
Reference23 articles.
1. Petrucelli N, Daly MB, Pal T (1998) BRCA1- and BRCA2-associated hereditary breast and ovarian cancer [Online]. Available at
https://www.ncbi.nlm.nih.gov/pubmed/20301425
. Accessed 1 Dec 2017
2. Papadaki C, Sfakianaki M, Ioannidis G, Lagoudaki E, Trypaki M, Tryfonidis K, Mavroudis D, Stathopoulos E, Georgoulias V, Souglakos J (2012) ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer. J Thorac Oncol 7(4):663–671
3. breastcancer.org (2017) HER2 status [Online]. Available at
http://www.breastcancer.org/symptoms/diagnosis/her2
. Accessed 1 Dec 2017
4. Soerjomataram I, Louwman MWJ, Ribot JG, Roukema JA, Coebergh JW (2008) An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 107(3):309–330
5. Murugan R (2015) Movement towards personalised medicine in the ICU. Lancet Respir Med 3(1):10–12
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献